Luxury Car, Boat Seized From Former NECC Head Pharmacist

A 2011 BMW M3 automobile and a 2010 luxury boat owned by Barry J. Cadden, former shareholder and head pharmacist of New England Compounding Center, were seized by federal agents after warrants for the assets were issued by the U.S. District Court in Boston.

The vehicle was seized yesterday from outside Cadden’s residence in Wrentham, and the boat was seized in North Kingston, R.I. on June 10, after both were identified in the indictment against Cadden as forfeitable property. In December 2014,

Cadden was charged in a 131-count indictment related to the 2012 fungal meningitis outbreak caused by contaminated vials of preservative-free methylprednisolone acetate that New England Compounding Center (NECC) manufactured.

The now-closed New England Compounding Center, which was located in Framingham, was linked to a deadly meningitis outbreak that killed 64 and injured more than 750 others.

Specifically, Cadden is charged with 25 acts of second-degree murder in Florida, Indiana, Maryland, Michigan, North Carolina, Tennessee, and Virginia, among other violations.

In addition, on May 22, 2015, the U.S. Attorney’s Office filed a civil forfeiture complaint against funds owned by Cadden and his wife, as well as those owned by Carla and Douglas A. Conigliaro. Carla Conigliaro, former shareholder of NECC, and her husband, Douglas Conigliaro, are also charged in the indictment with transferring millions of dollars the same month that NECC surrendered its pharmacy license and one month prior to NECC’s petition for bankruptcy in December 2012.

The Conigliaros also allegedly transferred millions of dollars more after the bankruptcy court issued two orders prohibiting NECC shareholders from transferring any assets. The assets named in the civil forfeiture complaint, which exceed $18 million, were seized pursuant to seizure warrants issued in December 2014.

A federal bankruptcy judge approved a $200 million compensation fund for victims of the meningitis outbreak linked to Framingham-based New England Compounding Center last month,